Subclinical Hyperthyroidism in Dementia and Correlation of the Metabolic Index in FDG-PET

Acta Medica Austriaca

Volumn 30, Issue 5, 2003, Pages 130-133

  Dobert N ^a   Hamscho, N ^a   Menzel, C ^a   Peters, J ^a   Frolich L ^a   Tsolakis, A ^a   Zaplatnikov, K ^a   Kratzsch, T ^a   Diener, J ^a   Maurer, K ^a   Grunwald F ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Dementia; Subclinical hyperthyroidism; TPO Abs; TSH

Indexed keywords

FLUORODEOXYGLUCOSE F 18; THYROID PEROXIDASE ANTIBODY; THYROTROPIN;

ADULT; AGED; ARTICLE; BRAIN METABOLISM; CLINICAL EXAMINATION; COMORBIDITY; CORRELATION FUNCTION; DEMENTIA; FEMALE; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; METABOLIC RATE; POSITRON EMISSION TOMOGRAPHY; THYROTROPIN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BASAL METABOLISM; BRAIN; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; HYPERTHYROIDISM; IMMUNOGLOBULINS, THYROID-STIMULATING; MALE; RADIOPHARMACEUTICALS; THYROTROPIN; THYROXINE; TOMOGRAPHY, EMISSION-COMPUTED; TRIIODOTHYRONINE;

EID: 9144226802     PISSN: 03038173     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bartenstein P, Grunwald F, Kuwert T, Tatsch K, Sabri O, Benkert O, Fahlbusch R, Grunder G, Herholz K, Weiller C: Clinical applications of single photon emission tomography in neurology. Dementia, psychoses, inflammation, skull and brain injuries. Nuklearmedizin 2000 Dec;39(8):218-232.
2. Baumgartner A, Campos-Barros A, Meinhold H: Thyroid hormones and depressive illness: implications for clinical and basic research. Acta Med Austriaca 1992;19 [Suppl 1]:98-102.
3. Constant EL, de Volder AG, Ivanoiu A, Bol A, Labar D, Seghers A, Cosnard G, Melin J, Daumerie C: Cerebral blood flow and glucose metabolism in hypothyroidism: a positron emission tomography study. J Clin Endocrinol Metab 2001;86: 3864-3870.
4. Cordes J, Cano J, Haupt M: Reversible Demenz bei Hypothyreose. Nervenarzt 2000;71:588-590.
5. Erzigkeit H: The SKT-A Short Cognitive Performance Test as an instrument for the assessment of clinical efficacy of cognition enhancers. In: Bergener M et al. (eds) Diagnosis and Treatment of Senile Dementia. Springer, Berlin Heidelberg New York Tokyo 1989;164-174.
6. Faldt R, Passant U, Nilsson K, Wattmo C, Gustafson L: Prevalence of thyroid hormone abnormalities in elderly patients with symptoms of organic brain disease. Aging 1996;8(5):47-53.
7. Finol HJ, Muller B, Torres SH, Dominguez JJ, Perdomo P, Montes de Oca I: Ultrastructural abnormalities in muscular vessels of hyperthyroid patients. Acta Neuropathol 1986;71:64-69.
8. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
9. Fukui T, Hasegawa Y, Takenaka H: Hyperthyroid dementia: Clinicoradiological findings and response of treatment. J Neurol Sci 2001;184(1):81-88.
10. Ghiso J, Frangione B: Amyloidosis and Alzheimer's disease. Adv Drug Deliv Rev 2002;7;54(12):1539-1551.
11. Kimura H, Yamashita S, Ashizawa K, Yokoyama N et al. Thyroid dysfunction in patients with amyloid goitre. Clin Endocrinol 1997;46(6):769-774.
12. Grünwald F, Horn R, Rieker O, Klemm E, Menzel C, Moller HJ, Biersack HJ: HMPAO-SPECT in Alzheimer-type dementia and major depression with memory disorders. Nuklearmedizin 1993 Jun;32(3):128-133.
13. Herholz K: FDG PET and Differential Diagnosis of Dementia. Alzheimer Dis Assoc Disord 1995;9:6-16.
14. Hertel A, Frölich L, Sengupta S, Hör G: FDG-PET and perfusion SPECT for early differential diagnosis of dementia in patients of a memory clinic. J Nucl Med 1999;40[Supp.5]:70.
15. Heyman A, Wilkinson WE, Stafford JA, Helms MJ, Sigmon AH, Weinberg T: Alzheimer's disease: a study of epidemiological aspects. Ann Neurol 1984;25: 335-341.
16. Hickie I, Bennett B, Mitchell P, Wilhelm K, Orlay W: Clinical and subclinical hypothyroidism in patients with chronic and treatment resistent depression. Aust N Z J Psychiatry 1996;30(2):246-252.
17. Hughes CP, Berg L, Danzinger WL, Coben LA: A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-572.
18. Kalmijn S, Mehta KM, Pols HA, Hofman A, Drexhage HA, Breteler MM: Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study. Clin Endocrinol 2000;53:733-737.
19. Katzman R, Aronson M, Fuld P, Kawas C, Brown T, Morgenstern H, Frishman W, Gidez L, Eder H, Ooi WL: Development of dementing illnesses in an 80-year-old volunteer cohort. Ann Neurol 1989;25:317-324.
20. Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C: The consortium to establish a registry for Alzheimer's disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989;39:1159-1160.
21. Prinz PN, Scanlan JM, Vitaliano PP, Moe KE, Borson S, Toivola B, Merriam GR, Larsen LH, Reed HL: Thyroid hormones: positive relationships with cognition in healthy, euthyroid older men. Gerontol A Biol Sci Med Sci 1999;54(3):M111-116.
22. Oatridge A, Barnard ML, Puri BK, Taylor-Robinson SD, Hajnal JV, Saeed N, Bydder GM: Changes in brain size with treatment in patients with hyper- or hypothyroidism. Am J Neuroradiol 2002;23(9):1539-1544.
23. Reisberg B, Ferris SH, de Leon MJ, Crook T: The global deterioration scale for assessment of primary degenerative dementia. Am J Psych 1982;139:1136-1139.
24. Rolland F, Chevrollier JP: Depression, anti-thyroid antibodies and Hashimoto encephalopathy. Encephale 2001;27(2):137-142.